Company intelligence / Profile preview
Syntara Limited
Frenchs Forest/Sydney, New South Wales, Australiasyntaratx.com.au ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
Syntara is a clinical-stage biotech developing small molecule drugs that inhibit key enzymes driving extracellular matrix dysfunction. Its lead candidate SNT‑5505 is in Phase 2 for myelofibrosis with positive interim data; additional programs target myelodysplastic syndrome, skin scarring/fibrosis, neuroinflammatory diseases like Parkinson’s disease, and organ fibrosis. The company has collaborations with academic groups and patient organizations such as Parkinson’s UK. It previously developed two commercial respiratory products for which it receives royalties.
- Therapeutic areas
- OncologyDermatologyOtherHematologyNeurology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
17 assets16 more assets in the full pipeline.
03
Partnerships
Parkinson's UK for neuroinflammation/Parkinson's programUniversity of Western Australia & Prof Fiona Wood for scar prevention/modificationHeidelberg University for MDS & CMML studies
Beyond the preview
Go deeper on Syntara Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Syntara Limited.